🇺🇸 FDA
Pipeline program

buprenorphine and low-dose naloxone

07-06-005

Unknown small_molecule completed

Quick answer

buprenorphine and low-dose naloxone for Pain is a Unknown program (small_molecule) at Indivior Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Indivior Pharmaceuticals
Indication
Pain
Phase
Unknown
Modality
small_molecule
Status
completed

Clinical trials